Skip to main content

Navigating Germline vs Somatic Testing in Cancer Care

Genomic tumor testing performed for treatment decision-making may also identify variants associated with hereditary cancer risk. However, interpreting possible hereditary or germline risks based on genomic tumor testing can be challenging. In this educational webinar, a multidisciplinary panel of clinical and laboratory experts will discuss case studies that highlight factors relevant for the interpretation of tumor results for hereditary risks.